Antiphospholipid syndrome primary prevention: Difference between revisions
Jump to navigation
Jump to search
Feham Tariq (talk | contribs) |
Feham Tariq (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Primary Prevention== | ==Primary Prevention== | ||
The primary prevention of antiphospholipid syndrome is as follows: | The primary prevention of antiphospholipid syndrome is as follows:<ref name="pmid24449256">{{cite journal| author=Nalli C, Andreoli L, Casu C, Tincani A| title=Management of recurrent thrombosis in antiphospholipid syndrome. | journal=Curr Rheumatol Rep | year= 2014 | volume= 16 | issue= 3 | pages= 405 | pmid=24449256 | doi=10.1007/s11926-013-0405-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24449256 }} </ref> | ||
* Anticoagulation in patients with risk factors for arterial and venous thrombosis. | * Anticoagulation in patients with risk factors for arterial and venous thrombosis. | ||
* Minimizing the contribution of reversible risk factors for recurrent thrombosis. | * Minimizing the contribution of reversible risk factors for recurrent thrombosis. | ||
Revision as of 18:44, 11 April 2018
|
Antiphospholipid syndrome Microchapters |
|
Differentiating Antiphospholipid syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Antiphospholipid syndrome primary prevention On the Web |
|
American Roentgen Ray Society Images of Antiphospholipid syndrome primary prevention |
|
Risk calculators and risk factors for Antiphospholipid syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
Primary Prevention
The primary prevention of antiphospholipid syndrome is as follows:[1]
- Anticoagulation in patients with risk factors for arterial and venous thrombosis.
- Minimizing the contribution of reversible risk factors for recurrent thrombosis.
- A daily low dose of aspirin for primary thrombosis prevention in asymptomatic individuals with persistent antiphospholipid antibodies.
References
- ↑ Nalli C, Andreoli L, Casu C, Tincani A (2014). "Management of recurrent thrombosis in antiphospholipid syndrome". Curr Rheumatol Rep. 16 (3): 405. doi:10.1007/s11926-013-0405-4. PMID 24449256.